|
2024
|
Invention
|
Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and metho... |
|
2023
|
Invention
|
Multi-arm polymer conjugates of tlr agonist compounds and related immunotherapeutic treatment met... |
|
|
Invention
|
Conjugates of a factor viii moiety having an oxime-containing linkage.
The present disclosure pr... |
|
2022
|
G/S
|
Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance for the tre... |
|
|
Invention
|
Dosing regimens for selective treg stimulator rur20kd-il-2 and related compositions.
The instant... |
|
|
Invention
|
Dosing regimens for selective treg stimulator rur20kd-il-2 and related compositions. The instant ... |
|
|
Invention
|
Polymer derivatives having particular atom arrangements.
Polymeric reagents are provided compris... |
|
|
Invention
|
Polymer engineered forms of interferon-gamma and methods of use. Provided is a conjugate comprisi... |
|
|
Invention
|
Histidine-selective polymer reagents.
The instant disclosure provides (among other things) novel... |
|
|
Invention
|
Histidine-selective polymer reagents. The instant disclosure provides (among other things) novel ... |
|
|
Invention
|
Composition comprising a polymeric reagent.
The present invention provides conjugates having a d... |
|
2021
|
Invention
|
Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method. Provided herein are ... |
|
|
Invention
|
Multi-arm polymer prodrugs.
Provided herein are water-soluble prodrugs, compositions comprising ... |
|
|
Invention
|
Oligomer-corticosteroid conjugates.
The invention provides corticosteroids that are chemically m... |
|
|
Invention
|
Tlr agonist compounds and related cancer immunotherapy methods. Provided herein are methods relat... |
|
|
Invention
|
Polymer-factor viii moiety conjugates.
Conjugates of a Factor VIII moiety and one or more water-... |
|
|
Invention
|
Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition. Methods of prepar... |
|
|
G/S
|
Pharmaceuticals, namely, pharmaceutical preparations for the treatment and/or prophylaxis of dise... |
|
|
Invention
|
Il-7 receptor agonist composition and related methods and uses. The instant disclosure is directe... |
|
|
Invention
|
Conjugates of an il-2 moiety and a polymer. Conjugates of an interleukin-2 (“IL-2”) moiety and on... |
|
|
Invention
|
Method for enhancing humoral immunity. The present disclosure provides, among other things, metho... |
|
|
Invention
|
Methods of treating cyp2d6 alternative metabolizers.
The invention provides various methods comp... |
|
|
Invention
|
Immunomodulator for the prevention and treatment of coronovirus infection and other conditions. P... |
|
|
Invention
|
Method for preparing functionalized polymers from polymer alcohols.
The present invention provid... |
|
|
Invention
|
Methods for preparing polymeric reagents and compositions of polymeric reagents.
Methods for pre... |
|
2020
|
Invention
|
Polymer factor ix moiety conjugates.
Conjugates of a Factor IX moiety and one or more water-solu... |
|
|
Invention
|
Alkoxylation methods. Among other aspects, provided herein is a mixed-acid salt of a water-solubl... |
|
|
Invention
|
Conjugates of an il-2 moiety and a polymer.
Conjugates of an interleukin-2 (“IL-2”) moiety and o... |
|
|
Invention
|
Il-2rbeta-selective agonists in combination with an anti-ctla-4 antibody or an anti-pd-1 antibody... |
|
|
Invention
|
Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds. Among other aspects, provid... |
|
|
Invention
|
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates... |
|
|
Invention
|
Polymer-sunitinib conjugates. The invention relates to (among other things) polymer-sunitinib con... |
|
|
Invention
|
Adenosine 2 receptor antagonists.
The instant disclosure provides novel adenosine receptor antag... |
|
|
Invention
|
Adenosine 2 receptor antagonists. The instant disclosure provides novel adenosine receptor antago... |
|
|
Invention
|
Polymer derivatives having particular atom arrangements. Polymeric reagents are provided comprisi... |
|
|
Invention
|
Method for enhancing cellular immunotherapy.
Provided are methods and compositions directed to t... |
|
|
Invention
|
Method for enhancing cellular immunotherapy. Provided are methods and compositions directed to th... |
|
|
Invention
|
Immunotherapeutic combination for treating cancer. Provided herein are methods, combinations, and... |
|
2019
|
Invention
|
Long-acting interleukin-15 receptor agonist in combination with another pharmacologically active ... |
|
|
Invention
|
Combination for treating cancer.
Provided herein are methods and combinations for treating a sub... |
|
|
Invention
|
Combinations for treating cancer.
Provided herein are methods and combinations for treating a su... |
|
|
Invention
|
Method of making releasable polymeric reagents. The instant disclosure provides (among other thin... |
|
|
Invention
|
Selective treg stimulator rur20kd-il-2 and related compositions.
The instant disclosure provides... |
|
2018
|
Invention
|
Methods of treating a tumor.
This disclosure provides methods for treating a tumor in a subject ... |
|
|
Invention
|
Immunotherapeutic combination for treating cancer.
Provided herein are methods and compositions ... |
|
|
Invention
|
Immunotherapeutic tumor treatment method. Disclosed herein are methods in the field of cancer imm... |
|
|
Invention
|
Immunotherapeutic tumor treatment method. Provided is a method of administering to a patient havi... |
|
2017
|
Invention
|
Conjugates of a factor viii moiety having an oxime-containing linkage. The present disclosure pro... |
|
2015
|
G/S
|
Pharmaceutical preparations, namely, an anti-cancer agent |
|
|
G/S
|
Pharmaceutical preparations, namely, an anti-cancer agent. |
|
|
G/S
|
Pharmaceutical preparations, namely an anti-cancer agent |
|
|
G/S
|
Pharmaceutical preparations, namely an anti-cancer agent. |
|
2014
|
G/S
|
pharmaceutical preparations, namely, an anti-cancer agent. |
|
2008
|
G/S
|
Research services, namely, providing research and development services for others in the biotechn... |
|
|
G/S
|
Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug... |
|
2005
|
G/S
|
Medical devices, namely, medical apparatus namely a unit for aerosol drug delivery to the deep lu... |
|
|
G/S
|
Pharmaceuticals, namely pharmaceutical preparations having
enhanced drug performance and/or drug... |
|
2003
|
G/S
|
Chemicals relating to drug performance and/or drug delivery performance for research use and manu... |
|
2002
|
G/S
|
Chemicals used in industry and science, as well as in agriculture, horticulture and forestry; unp... |
|
|
G/S
|
research services, namely, providing research and development services for others in the biotechn... |
